REQUEST A DEMO
Total
USD $0.00
Search more companies

Ronald Pharmaceuticals Private Limited (India)

Main Activities: Basic Chemical Manufacturing
Full name: Ronald Pharmaceuticals Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Ronald Pharmaceuticals Private Limited is based in India, with the head office in Vadodara. It operates in the Basic Chemical Manufacturing industry. It was established on April 26, 1993. From the latest financial highlights, Ronald Pharmaceuticals Private Limited reported a net sales revenue drop of 11.79% in 2024. A growth of 24.34% was recorded in its total assets. In, 2024, the company’s net profit margin decreased by 1.48%.

Legal Address
Block No 740/Aat Manjusar Tal Savli
Vadodara; Gujarat; Postal Code: 390007

Contact Details: Purchase the Ronald Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Ronald Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Ronald Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
April 26, 1993
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
49.71%
Purchase this report to view the information.
25.01%
Company Performance
Financial values in the chart are available after Ronald Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-11.79%
Total Operating Revenue
-11.61%
Operating Profit
-23.95%
EBITDA
-18.86%
Net Profit/Loss for the Period
-43.88%
Total Assets
24.34%
Total Equity
14.91%
Operating Profit Margin
-0.91%
Net Profit Margin
-1.48%
Return on Equity (ROE)
-13.59%
Debt / Equity
9.24%
Quick Ratio
0.12%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?